Início
Mercados
Gráficos e ideias
Algo
Notícias
Store
Corretoras
Baixar
Calendário econômico
Sinais de Negociação
Terminal web
Pressione
/
para pesquisar: @user, $symbol, ...
Pesquisar
Login
Criar uma conta
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
PRME
#2265
Prime Medicine, Inc. Common Stock
4.6
2
+7.94%
Setor:
Base:
Moeda do lucro:
Faixa diária
Faixa anual
Mudança diária
+7.94%
Mudança mensal
+6.21%
Mudança em 6 meses
+35.48%
Mudança anual
+87.04%
Fechamento anterior
4.2
8
Open
4.6
2
Bid
Ask
Low
4.6
2
High
4.6
2
Volume
111
Mercados
Ações
Cuidados de saúde
PRME
Open full chart
Financials
Overview
Relatórios
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
TTM
Dividends per share
—
—
—
—
—
—
Dividend yield %
—
—
—
—
—
—
Payout ratio %
—
—
—
—
—
—
Notícias
Vanda Pharmaceuticals (VNDA) Reports Q4 Loss, Lags Revenue Estimates
Prime Drink Group completes first closing of private placement
Prime: Maintaining "Buy" On Solidified Catalysts For Wilson's Disease And Beyond
Prime Drink Group announces private placement to raise up to $5 million
Goldman Sachs reiterates Early-Stage Biotech rating on Prime Medicine stock
Prime Medicine, Inc. (PRME) Reports Q3 Loss, Lags Revenue Estimates
Prime Medicine appoints Matthew Hawryluk as chief business officer
NovoCure (NVCR) Reports Q3 Loss, Tops Revenue Estimates
Prime Medicine Momentum Amid Pipeline Progress: Why I Choose To 'Hold' For Now (PRME)
Cathie Wood’s ARK ETF adjusts stock positions, buys PRME and TWST
Prime Drink Group shifts from rights offering to private placement
Google, Apple Lead Mega-Cap Movers on a Volatile Wednesday